protein synthesis in other eukaryotes. We have identified and isolated a gene for EF-3 from P. carinii, adding more evidence for this organism's assignment as a fungus.
The severely immunocompromised status of patients with AIDS as well as of patients receiving immunosuppressive treatment allows opportunistic infection with a number of organisms. Historically, Pneumocystis carinii pneumonia (PCP) has been the most frequent cause of morbidity and mortality in patients with AIDS. Up to 80% of adult and 40% of pediatric patients with AIDS have contracted PCP at least once (1, 23) . After successful treatment of PCP, a prophylactic treatment regimen is usually required because of the high probability of recurrent infection. P. carinii is a eukaryotic organism that primarily infects the lungs of a range of mammalian hosts, including humans, rats, and mice. Two morphological forms of P. carinii, the trophozoite and cyst, have been observed in infected lungs. The trophozoite often attaches to the pneumocytes, contains a single nucleus, and is irregularly shaped. The trophozoite appears to encapsulate into the thick-walled cyst, which contains up to eight singly nucleated intracystic bodies. The cysts are invariably round and remain unattached in the air sacs. It is not clear whether the trophozoite, the cyst, or another, unidentified form of the organism is infectious (5) .
The taxonomic position of P. carinii within the eukaryotes has been unclear, and for years the literature has contained arguments for including P. carinii either among the fungi or among the protozoa (11) . Classification has relied primarily on morphogical and ultrastructural data, as detailed examination of the biochemistry and genetics of P. carinii was severely hampered by the inability to propagate any form of the organism in vitro (3) . P. carinii has been included among the protozoa because of morphological similarities to various protozoa (2, 30, 31) . The microtubule arrangement, ultrastructure (28) , and DNA content per cell (10) of P. canrnii have been reported to be closest to those of various protozoans. In addition, Pneumocystis infections respond to antiprotozoan drugs, including trimethoprim-sulfamethoxazole and pentamidine, but not to currently used antifungal drugs.
However, several features of P. carinii have been interpreted as being characteristic of fungi (14, 16) . P. carinii has staining properties consistent with a fungus, and a component of the cyst wall is 0-1,3-glucan, a major component of * Corresponding author. fungal cell walls (15) . Chitin, a macromolecule present in but not uniquely specific to fungi, has been detected in both the cyst and trophozoite (29) . Moreover, the process of cyst formation resembles the meiotic process of the ascomycetes (32). Edman et al. (8) compared the sequence of the Pneumocystis 16S rRNA gene with those of the 16S rRNA genes of a variety of organisms (including protozoans) and found that this sequence was most similar to that of the yeast Saccharomyces cerevisiae. Subsequent analysis of the Pneumocystis thymidylate synthase (TS) gene similarly demonstrated that the deduced amino acid sequence is most similar to that of TS from S. cerevisiae and showed 65% identity between the proteins (9) . In addition, the Pneumocystis TS and dihydrofolate reductase are separate proteins (7, 13) , in contrast to protozoan TS and dihydrofolate reductase activities, which reside within a single polypeptide. A comparative sequence analysis of several Pneumocystis mitochondrial DNA genes has been reported and suggests that P. carinii is a fungus (20) . Partial sequence analysis of the Pneumocystis 0-tubulin gene also showed that it was most similar to the corresponding gene in dimorphic fungi (6) .
In order to more clearly classify P. carinii, we investigated whether the organism contained the gene for a fungusspecific protein, translation elongation factor 3 (EF-3). Polypeptide elongation during protein synthesis in eukaryotic cells requires elongation factor 1 (EF-1) and EF-2. However, elongation in fungi requires a third, soluble component, EF-3 (25, 26) . While EF-1 and EF-2 of fungi and higher eukaryotes are functionally interchangeable (22) , EF-3 is unique to fungi. EF-3 was initially identified in S. cerevisiae cell extracts and consists of a 125-kDa monomeric protein (4) .
While the exact role of EF-3 in translation is unresolved, EF-3 exhibits ribosome-dependent GTPase and ATPase activities (4, 27) . Biochemical and Western (immunoblot) analyses have shown that EF-3 is present in many yeast species and in filamentous fungi, such as Neurospora, Aspergillus, and Mucor spp. However, such analyses have failed to detect an EF-3 analog in Tetrahymena spp., Chlamydomonas spp., brine shrimp, rat liver, or HeLa cells (17, 21, 24) . Considering that the configuration of the translational apparatus is different in protozoan and fungal systems, the identification of EF-3 in P. carinii would further clarify the affiliation of P. carinii with the fungi. This report (19) . The hybridization and wash conditions are described below. Several hybridizing plaques were identified with the S. cerevisiae EF-3 probe. Phagemids were rescued by coinfection of E. coli XL1-Blue with the appropriate lambda phage and R408 helper phage, as recommended by Stratagene. Isolate pPCEF-3-6.5 contained a 6.5-kb insert. Subsequent mapping of pPCEF-3-6.5 showed that an internal 3.5-kb region of the insert hybridized specifically to the S. cerevisiae probe. The internal 3.5-kb region was mapped with several restriction enzymes. Two XhoI fragments (1,550 and 1,507 bp, Fig. 1A ) contained the majority of the hybridizing sequences and were subcloned into the Bluescript SK+ vector (Stratagene), yielding pEFX1 and pEFX2, respectively. In order to see whether the S. cerevisiae probe was hybridizing to other genes in the lambda library (in addition to the putative EF-3 gene), DNA from two additional phagemids was analyzed. Southern analysis showed that these phagemids contained a subset of the sequence in pPCEF-3-6.5 (data not shown), and only the putative EF-3 gene was hybridizing to the heterologous probe.
Probe preparation and hybridization conditions. A 3. Nucleotide sequence accession number. The 3,274-nucleotide sequence, which includes the coding sequence of P. caninii EF-3 as well as 5'-and 3'-flanking sequences, may be retrieved from GenBank by using accession number M87665.
RESULTS
Isolation of the Pneumocystis EF-3 gene. In order to identify the Pneumocystis EF-3 gene, we screened a lambda library containing Pneumocystis genomic DNA with the Saccharomyces EF-3 gene as a heterologous probe (21) . By hybridizing under nonstringent conditions, we identified a clone (pPCEF-3-6.5) which contained a 3.5-kb sequence that hybridized specifically to the probe. Sequencing of the pPCEF-3-6.5 phagemid and its subclones showed a single open reading frame of 3,126 nucleotides, coding for a deduced protein of 1,042 amino acids.
Comparative Southern analysis of genomic and cloned Pneumocystis DNA. The genomic lambda ZAPI library was constructed with DNA extracted from organisms which were partially purified from infected lung tissue. In order to confirm that the putative EF-3 sequence we had isolated from the library was indeed from P. carindi and not from contaminating fungi, we compared the restriction pattern of the cloned putative EF-3 sequence with that of genomic DNA isolated from P. carinii cultured on a human embryonic lung cell line. The in vitro-derived organisms were free of bacterial and fungal contamination. The genomic Pneumocystis DNA was digested with a several restriction enzymes and probed with pPCEF-3-6.5-derived sequences (Fig. 1B) . Because Figure 1C shows the patterns predicted from the sequence data for the cloned EF-3 gene. As the restriction patterns generated from the genomic DNA are identical to those predicted from the cloned gene, we conclude that the EF-3 gene which we cloned originated from P. carinii. Despite the high degree of similarity between the deduced amino acid sequences of the P. caninii, S. cerevisiae, and C. albicans EF-3's, codon usage While the Candida EF-3 sequence showed 78% identity to that of the S. cerevisiae protein, the Pneumocystis and Candida EF-3 sequences showed 57% identity. Detailed comparison of the three EF-3 sequences showed several regions of identity from residue 425 to the carboxy termini of the proteins. In particular, the Pneumocystis EF-3 sequence includes two short amino acid sequence motifs (underlined and double-underlined in Fig. 2 (19, 21) , and colinear alignment of the three deduced amino acid sequences suggests that the Pneumocystis gene does not contain an intron(s). However, several Pneumocystis genes have short introns (7, 9) , and sequencing of a cDNA of the EF-3 gene is necessary to confirm the lack of introns.
Comparison of the Pneumocystis, Saccharomyces, and Candida EF-3 deduced amino acid sequences highlights several regions of identity from residues 425 to the carboxy termini of the proteins. In particular, the Pneumocystis EF-3 sequence includes two amino acid sequence motifs, each of which appears in duplicate within the protein (Fig. 2) . These motifs are almost identical to the analogous motifs first observed in Saccharomyces EF-3 by Qin et al. (21) , as well as in the EF-3 of C. albicans (19 unclear, it is possible that the carboxy-terminal sequences of EF-3 interact either with rRNA or perhaps with tRNA. Significantly, the deduced amino-terminal sequences of the Saccharomyces, Pneumocystis, and Candida EF-3 proteins show limited similarity.
The identification of the EF-3 gene in P. carinii is the first documentation of a fungus-specific gene in the Pneumocystis genome and suggests that P. carinii elongates proteins in a fungus-specific manner. Surprisingly, Jackson et al. (12) have recently reported that Western blot analysis with polyclonal antibody raised against Saccharomyces EF-3 failed to detect EF-3 in lysates of partially purified P. carinii. There are several possible scenarios which would reconcile these seemingly conflicting results. It is possible that the Pneumocystis EF-3 gene is vestigial and is not expressed. However, the identity between specific regions of the Saccharomyces, Candida, and Pneumocystis proteins suggests that there has been selection against mutations creating changes in functionally or structurally important regions of Pneumocystis EF-3 and implies EF-3 expression. It is also possible that the organisms, which were primarily noncystic, were not metabolically active and were not expressing EF-3 at appreciable levels. The alignment data also show marked heterogeneity in the first 425 residues between the Pneumocystis and Saccharomyces proteins. If EF-3 was not expressed at high levels and the heterogeneity between the EF-3 proteins was significant enough to compromise the reactivity of the antiserum, it is possible that Pneumocystis EF-3 would not be detected.
The translational apparatus is the site of action of many useful antibiotics. If a unique translation elongation factor, such as EF-3, is expressed in P. caninii, it may provide a suitable target for an inhibitor which is free of toxic side effects. The current drug protocols used to treat PCP are moderately successful in some cases, but these drugs were not originally designed for this organism and do not reflect any knowledge of its metabolism or structure. Detailed analysis of EF-3 could provide information on translationspecific target sites for anti-P. cannii drug therapy.
